BRCA1 exon 11 a model of long exon splicing regulation

RNA Biology

Volumn 11, Issue 4, 2014, Pages 351-359

  Raponi, Michela ^a   Smith, Lindsay D ^a   Silipo, Marco ^a   Stuani, Cristiana ^b   Buratti, Emanuele ^b   Baralle, Diana ^a  

^a UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^b INTERNATIONAL CENTRE FOR GENETIC ENGINEERING AND BIOTECHNOLOGY   (Italy)

Author keywords

Alternative splicing; BRCA; BRCA1; Donor site; Exon11; HnRNPL; Splicing; Tra2B; Tra2beta

Indexed keywords

BRCA1 PROTEIN; HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN L; HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN; NERVE PROTEIN; POLYPYRIMIDINE TRACT BINDING PROTEIN; RNA BINDING PROTEIN; RNA ISOFORM; RNA SPLICING; TRA2B PROTEIN, HUMAN;

ARTICLE; CONTROLLED STUDY; DOWN REGULATION; ENHANCER REGION; EXON; HUMAN; HUMAN CELL; INTRON; PROTEIN ANALYSIS; PROTEIN RNA BINDING; RNA SEQUENCE; RNA SPLICING; UPREGULATION; ALTERNATIVE RNA SPLICING; BIOLOGICAL MODEL; CELL LINE; GENE DELETION; GENE EXPRESSION REGULATION; METABOLISM; TUMOR SUPPRESSOR GENE;

ALTERNATIVE SPLICING; CELL LINE; EXONS; GENE EXPRESSION REGULATION; GENES, BRCA1; HETEROGENEOUS-NUCLEAR RIBONUCLEOPROTEIN GROUP F-H; HETEROGENEOUS-NUCLEAR RIBONUCLEOPROTEIN L; HUMANS; MODELS, BIOLOGICAL; NERVE TISSUE PROTEINS; POLYPYRIMIDINE TRACT-BINDING PROTEIN; RNA ISOFORMS; RNA SPLICE SITES; RNA SPLICING; RNA-BINDING PROTEINS; SEQUENCE DELETION;

EID: 84901398341     PISSN: 15476286     EISSN: 15558584     Source Type: Journal    
DOI: 10.4161/rna.28458     Document Type: Article

References (29)

1. House AE, Lynch KW. Regulation of alternative splicing: more than just the ABCs. J Biol Chem 2008; 283:1217-21; PMID:18024429; http://dx.doi.org/10. 1074/jbc.R700031200
2. Heyd F, Lynch KW. Degrade, move, regroup: signaling control of splicing proteins. Trends Biochem Sci 2011; 36:397-404; PMID:21596569; http://dx.doi.org/10.1016/j.tibs.2011.04.003
3. Brown SJ, Stoilov P, Xing Y. Chromatin and epigenetic regulation of pre-mRNA processing. Hum Mol Genet 2012; 21(R1):R90-6; PMID:22936691; http://dx.doi.org/10.1093/hmg/dds353
4. Orban TI, Olah E. Emerging roles of BRCA1 alternative splicing. [Review]. Mol Pathol 2003; 56:191-7; PMID:12890739; http://dx.doi.org/10.1136/mp.56.4.191
5. Okumura N, Yoshida H, Kitagishi Y, Nishimura Y, Matsuda S. Alternative splicings on p53, BRCA1 and PTEN genes involved in breast cancer. [Review]. Biochem Biophys Res Commun 2011; 413:395-9; PMID:21893034; http://dx.doi.org/10. 1016/j.bbrc.2011.08.098
6. Tammaro C, Raponi M, Wilson DI, Baralle D. BRCA1 exon 11 alternative splicing, multiple functions and the association with cancer. Biochem Soc Trans 2012; 40:768-72; PMID:22817731; http://dx.doi.org/10.1042/BST20120140
7. Zhang L, Chen L, Bacares R, Ruggeri JM, Somar J, Kemel Y, Stadler ZK, Offit K. BRCA1 R71K missense mutation contributes to cancer predisposition by increasing alternative transcript levels. Breast Cancer Res Treat 2011; 130:1051-6; PMID:21863257; http://dx.doi.org/10.1007/s10549-011-1732-7
8. Raponi M, Kralovicova J, Copson E, Divina P, Eccles D, Johnson P, Baralle D, Vorechovsky I. Prediction of single-nucleotide substitutions that result in exon skipping: identification of a splicing silencer in BRCA1 exon 6. Hum Mutat 2011; 32:436-44; PMID:21309043; http://dx.doi.org/10.1002/humu.21458
9. Sanz DJ, Acedo A, Infante M, Durán M, Pérez-Cabornero L, Esteban-Cardeñosa E, Lastra E, Pagani F, Miner C, Velasco EA. A high proportion of DNA variants of BRCA1 and BRCA2 is associated with aberrant splicing in breast/ovarian cancer patients. Clin Cancer Res 2010; 16:1957-67; PMID:20215541; http://dx.doi.org/10.1158/1078-0432.CCR-09-2564
10. Raponi M, Douglas AG, Tammaro C, Wilson DI, Baralle D. Evolutionary constraint helps unmask a splicing regulatory region in BRCA1 exon 11. PLoS One 2012; 7:e37255; PMID:22615956; http://dx.doi.org/10.1371/journal.pone.0037255
11. Orban TI, Olah E. Expression profiles of BRCA1 splice variants in asynchronous and in G1/S synchronized tumor cell lines. Biochem Biophys Res Commun 2001; 280: 32-8; PMID:11162473; http://dx.doi.org/10.1006/bbrc.2000.4068
12. Favy DA, Lafarge S, Rio P, Vissac C, Bignon YJ, Bernard-Gallon D. Real-time PCR quantification of full-length and exon 11 spliced BRCA1 transcripts in human breast cancer cell lines. Biochem Biophys Res Commun 2000; 274:73-8; PMID:10903898; http://dx.doi.org/10.1006/bbrc.2000.3100
13. Lu M, Conzen SD, Cole CN, Arrick BA. Characterization of functional messenger RNA splice variants of BRCA1 expressed in nonmalignant and tumor-derived breast cells. Cancer Res 1996; 56:4578-81; PMID:8840964
14. Hung LH, Heiner M, Hui J, Schreiner S, Benes V, Bindereif A. Diverse roles of hnRNP L in mammalian mRNA processing: a combined microarray and RNAi analysis. RNA 2008; 14:284-96; PMID:18073345; http://dx.doi.org/10.1261/rna. 725208
15. Rossbach O, Hung LH, Schreiner S, Grishina I, Heiner M, Hui J, Bindereif A. Auto- and cross-regulation of the hnRNP L proteins by alternative splicing. Mol Cell Biol 2009; 29:1442-51; PMID:19124611; http://dx.doi.org/10.1128/MCB. 01689-08
16. Clark SL, Rodriguez AM, Snyder RR, Hankins GD, Boehning D. Structure-Function Of The Tumor Suppressor BRCA1. Comput Struct Biotechnol J 2012; 1:e201204005; PMID:22737296
17. Grellscheid S, Dalgliesh C, Storbeck M, Best A, Liu Y, Jakubik M, Mende Y, Ehrmann I, Curk T, Rossbach K, et al. Identification of evolutionarily conserved exons as regulated targets for the splicing activator tra2β in development. PLoS Genet 2011; 7:e1002390; PMID:22194695; http://dx.doi.org/10. 1371/journal.pgen.1002390
18. Shin C, Manley JL. The SR protein SRp38 represses splicing in M phase cells. Cell 2002; 111:407-17; PMID:12419250; http://dx.doi.org/10.1016/S0092- 8674(02)01038-3
19. Motta-Mena LB, Heyd F, Lynch KW. Context-dependent regulatory mechanism of the splicing factor hnRNP L. Mol Cell 2010; 37:223-34; PMID:20122404; http://dx.doi.org/10.1016/j.molcel.2009.12.027
20. Paz I, Akerman M, Dror I, Kosti I, Mandel-Gutfreund Y. SFmap: a web server for motif analysis and prediction of splicing factor binding sites. Nucleic Acids Res 2010; 38:W281-5; PMID:20501600; http://dx.doi.org/10.1093/nar/ gkq444
21. Piva F, Giulietti M, Burini AB, Principato G. SpliceAid 2: a database of human splicing factors expression data and RNA target motifs. Hum Mutat 2012; 33:81-5; PMID:21922594; http://dx.doi.org/10.1002/humu.21609
22. Desmet FO, Hamroun D, Lalande M, Collod-Béroud G, Claustres M, Béroud C. Human Splicing Finder: an online bioinformatics tool to predict splicing signals. Nucleic Acids Res 2009; 37:e67; PMID:19339519; http://dx.doi.org/10.1093/nar/gkp215
23. Yeo G, Burge CB. Maximum entropy modeling of short sequence motifs with applications to RNA splicing signals. J Comput Biol 2004; 11:377-94; PMID:15285897; http://dx.doi.org/10.1089/1066527041410418
24. Ho SN, Hunt HD, Horton RM, Pullen JK, Pease LR. Site-directed mutagenesis by overlap extension using the polymerase chain reaction. Gene 1989; 77:51-9; PMID:2744487; http://dx.doi.org/10.1016/0378-1119(89)90358-2
25. Grellscheid SN, Dalgliesh C, Rozanska A, Grellscheid D, Bourgeois CF, Stévenin J, Elliott DJ. Molecular design of a splicing switch responsive to the RNA binding protein Tra2β. Nucleic Acids Res 2011; 39:8092-104; PMID:21724598; http://dx.doi.org/10.1093/nar/gkr495
26. Kralovicova J, Vorechovsky I. Allele-specific recognition of the 3' splice site of INS intron 1. Hum Genet 2010; 128:383-400; PMID:20628762; http://dx.doi.org/10.1007/s00439-010-0860-1
27. Paul S, Dansithong W, Kim D, Rossi J, Webster NJ, Comai L, Reddy S. Interaction of muscleblind, CUG-BP1 and hnRNP H proteins in DM1-associated aberrant IR splicing. EMBO J 2006; 25:4271-83; PMID:16946708; http://dx.doi.org/10.1038/sj.emboj.7601296
28. Preussner M, Schreiner S, Hung LH, Porstner M, Jäck HM, Benes V, Rätsch G, Bindereif A. HnRNP L and L-like cooperate in multiple-exon regulation of CD45 alternative splicing. Nucleic Acids Res 2012; 40:5666-78; PMID:22402488; http://dx.doi.org/10.1093/nar/gks221
29. Raponi M, Buratti E, Llorian M, Stuani C, Smith CW, Baralle D. Polypyrimidine tract binding protein regulates alternative splicing of an aberrant pseudoexon in NF1. FEBS J 2008; 275:6101-8; PMID:19016857; http://dx.doi.org/10.1111/j.1742-4658.2008.06734.x